vs

Side-by-side financial comparison of Soluna Holdings, Inc (SLNH) and Taysha Gene Therapies, Inc. (TSHA). Click either name above to swap in a different company.

Soluna Holdings, Inc is the larger business by last-quarter revenue ($8.4M vs $5.5M, roughly 1.5× Taysha Gene Therapies, Inc.). Soluna Holdings, Inc runs the higher net margin — -284.7% vs -507.8%, a 223.1% gap on every dollar of revenue. On growth, Taysha Gene Therapies, Inc. posted the faster year-over-year revenue change (171.3% vs 11.8%). Over the past eight quarters, Taysha Gene Therapies, Inc.'s revenue compounded faster (26.8% CAGR vs -8.8%).

Taysha Gene Therapies, Inc. is a clinical-stage biotechnology company specializing in developing adeno-associated virus (AAV)-based gene therapies for rare monogenic central nervous system disorders with high unmet medical needs. Its core pipeline targets serious life-threatening neurological conditions, with primary operations and market focus across North America and European regions.

SLNH vs TSHA — Head-to-Head

Bigger by revenue
SLNH
SLNH
1.5× larger
SLNH
$8.4M
$5.5M
TSHA
Growing faster (revenue YoY)
TSHA
TSHA
+159.4% gap
TSHA
171.3%
11.8%
SLNH
Higher net margin
SLNH
SLNH
223.1% more per $
SLNH
-284.7%
-507.8%
TSHA
Faster 2-yr revenue CAGR
TSHA
TSHA
Annualised
TSHA
26.8%
-8.8%
SLNH

Income Statement — Q3 FY2025 vs Q4 FY2025

Metric
SLNH
SLNH
TSHA
TSHA
Revenue
$8.4M
$5.5M
Net Profit
$-24.0M
$-27.9M
Gross Margin
9.5%
Operating Margin
-92.5%
-516.0%
Net Margin
-284.7%
-507.8%
Revenue YoY
11.8%
171.3%
Net Profit YoY
-233.2%
-48.3%
EPS (diluted)
$-1.14
$-0.08

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
SLNH
SLNH
TSHA
TSHA
Q4 25
$5.5M
Q3 25
$8.4M
$0
Q2 25
$6.2M
$2.0M
Q1 25
$5.9M
$2.3M
Q4 24
$8.3M
$2.0M
Q3 24
$7.5M
$1.8M
Q2 24
$9.7M
$1.1M
Q1 24
$12.5M
$3.4M
Net Profit
SLNH
SLNH
TSHA
TSHA
Q4 25
$-27.9M
Q3 25
$-24.0M
$-32.7M
Q2 25
$-7.4M
$-26.9M
Q1 25
$-7.6M
$-21.5M
Q4 24
$-40.0M
$-18.8M
Q3 24
$-7.2M
$-25.5M
Q2 24
$-10.9M
$-20.9M
Q1 24
$-5.3M
$-24.1M
Gross Margin
SLNH
SLNH
TSHA
TSHA
Q4 25
Q3 25
9.5%
Q2 25
6.3%
Q1 25
5.7%
Q4 24
-360.8%
Q3 24
-39.1%
Q2 24
34.6%
Q1 24
45.4%
Operating Margin
SLNH
SLNH
TSHA
TSHA
Q4 25
-516.0%
Q3 25
-92.5%
Q2 25
-107.6%
-1347.1%
Q1 25
-120.9%
-930.5%
Q4 24
-426.0%
-985.8%
Q3 24
-119.8%
-1448.4%
Q2 24
-38.0%
-1915.4%
Q1 24
3.2%
-713.3%
Net Margin
SLNH
SLNH
TSHA
TSHA
Q4 25
-507.8%
Q3 25
-284.7%
Q2 25
-119.9%
-1353.6%
Q1 25
-127.3%
-935.2%
Q4 24
-483.8%
-929.0%
Q3 24
-95.5%
-1427.5%
Q2 24
-112.4%
-1882.0%
Q1 24
-41.9%
-705.4%
EPS (diluted)
SLNH
SLNH
TSHA
TSHA
Q4 25
$-0.08
Q3 25
$-1.14
$-0.09
Q2 25
$-0.93
$-0.09
Q1 25
$-1.21
$-0.08
Q4 24
$-7.14
$-0.07
Q3 24
$-1.56
$-0.10
Q2 24
$-3.62
$-0.09
Q1 24
$-2.62
$-0.10

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
SLNH
SLNH
TSHA
TSHA
Cash + ST InvestmentsLiquidity on hand
$319.8M
Total DebtLower is stronger
$13.3M
Stockholders' EquityBook value
$14.5M
$246.9M
Total Assets
$152.0M
$343.3M
Debt / EquityLower = less leverage
0.92×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
SLNH
SLNH
TSHA
TSHA
Q4 25
$319.8M
Q3 25
$297.3M
Q2 25
$312.8M
Q1 25
$116.6M
Q4 24
$139.0M
Q3 24
$157.7M
Q2 24
$172.7M
Q1 24
$124.0M
Total Debt
SLNH
SLNH
TSHA
TSHA
Q4 25
Q3 25
$13.3M
Q2 25
$10.0M
Q1 25
$10.2M
Q4 24
$7.1M
Q3 24
$8.1M
Q2 24
$9.0M
Q1 24
Stockholders' Equity
SLNH
SLNH
TSHA
TSHA
Q4 25
$246.9M
Q3 25
$14.5M
$219.0M
Q2 25
$-19.5M
$248.7M
Q1 25
$-16.1M
$55.1M
Q4 24
$-12.5M
$71.5M
Q3 24
$20.9M
$88.8M
Q2 24
$24.4M
$108.9M
Q1 24
$21.5M
$53.8M
Total Assets
SLNH
SLNH
TSHA
TSHA
Q4 25
$343.3M
Q3 25
$152.0M
$316.6M
Q2 25
$92.0M
$333.3M
Q1 25
$90.0M
$138.4M
Q4 24
$88.0M
$160.4M
Q3 24
$97.3M
$180.2M
Q2 24
$98.7M
$200.4M
Q1 24
$90.6M
$153.0M
Debt / Equity
SLNH
SLNH
TSHA
TSHA
Q4 25
Q3 25
0.92×
Q2 25
Q1 25
Q4 24
Q3 24
0.39×
Q2 24
0.37×
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
SLNH
SLNH
TSHA
TSHA
Operating Cash FlowLast quarter
$-2.2M
$-26.7M
Free Cash FlowOCF − Capex
$-6.8M
FCF MarginFCF / Revenue
-81.4%
Capex IntensityCapex / Revenue
55.2%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-34.4M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
SLNH
SLNH
TSHA
TSHA
Q4 25
$-26.7M
Q3 25
$-2.2M
$-24.2M
Q2 25
$-1.1M
$-20.2M
Q1 25
$-177.0K
$-22.0M
Q4 24
$-5.1M
$-18.3M
Q3 24
$61.0K
$-21.6M
Q2 24
$-7.3M
$-21.5M
Q1 24
$3.9M
$-19.8M
Free Cash Flow
SLNH
SLNH
TSHA
TSHA
Q4 25
Q3 25
$-6.8M
$-24.3M
Q2 25
$-9.7M
Q1 25
$-4.0M
Q4 24
$-13.9M
$-18.3M
Q3 24
$-3.4M
$-21.6M
Q2 24
$-7.6M
$-21.7M
Q1 24
$3.3M
$-19.9M
FCF Margin
SLNH
SLNH
TSHA
TSHA
Q4 25
Q3 25
-81.4%
Q2 25
-156.8%
Q1 25
-67.1%
Q4 24
-168.3%
-905.5%
Q3 24
-44.8%
-1210.9%
Q2 24
-78.2%
-1951.9%
Q1 24
26.5%
-584.5%
Capex Intensity
SLNH
SLNH
TSHA
TSHA
Q4 25
Q3 25
55.2%
Q2 25
139.0%
Q1 25
64.2%
Q4 24
107.0%
0.1%
Q3 24
45.6%
2.0%
Q2 24
2.5%
18.1%
Q1 24
4.2%
4.1%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

SLNH
SLNH

Data Hosting Revenue$5.3M62%
Cryptocurrency Mining Revenue$2.8M33%
Other$389.0K5%

TSHA
TSHA

Segment breakdown not available.

Related Comparisons